title: Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
abstract: In December 2008, bimatoprost ophthalmic solution 0.03% was approved in the United States for the treatment of hypotrichosis of the eyelashes. Since then, there have been several reports in the literature on the off-label use of bimatoprost ophthalmic solution 0.03% for the treatment of thinning in other hair bearing areas, such as in the eyebrows and in the scalp. Herein, a prospective pilot study is presented in which bimatoprost ophthalmic solution 0.03% is evaluated for helping to re-grow hair in the eyebrow region of ten female patients.
authors.affiliation: University of Medicine and Dentistry of New Jersey, Rutgers University.
authors.forename: Irene J
authors.initials: IJ
authors.lastname: Vergilis-Kalner
mesh_terms: D000328:Adult; D000577:Amides / Q000627:therapeutic use*; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005138:Eyebrows; D005140:Eyelashes; D005260:Female; D006801:Humans; D007039:Hypotrichosis / Q000188:drug therapy*; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D017060:Patient Satisfaction; D010865:Pilot Projects; D011446:Prospective Studies
chemical_list: D000577:Amides; D009883:Ophthalmic Solutions; D003008:Cloprostenol; D000069580:Bimatoprost